An Impella update, another TAVI vs SAVR trial, two studies on angina and PCI, another null substudy from REVIVED-BCIS, and semaglutide are the topics John Mandrola, MD, covers in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
www.medscape.com/twic
I. Impella Update

• CHRIP BCIS 3 classic.clinicaltrials.gov/ct...
• Danger-Shock Podcast www.medscape.com/viewarticle/...
II. TAVI vs SAVR

• Notion 2 Trial EHJ doi.org/10.1093/eurheartj/eha...
• DEDICATE-DZHK6
III. Angina and PCI

• Orbita 2 Sub-analysis
• Orbita Star www.jacc.org/doi/10.1016/j.ja...
IV. Complete Revascularization

• Main REVIVED trial www.nejm.org/doi/full/10.1056...
• JACC Substudy www.jacc.org/doi/10.1016/j.ja...
V. Semaglutide
Semaglutide CV Benefits Irrespective of Weight Loss: 4-Year SELECT Data
www.medscape.com/viewarticle/...

• Nature Med substudy www.nature.com/articles/s4159...
• SELECT Main paper www.nejm.org/doi/full/10.1056...
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. www.medscape.com/author/bob-h...
Questions or feedback, please contact news@medscape.net